Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Tegoprazan-amoxicillin dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Telbivudine
Chinese University of Hong Kong
Chronic Hepatitis B
1 trial -
Tenofovir Disoproxil Fumarate
The First People's Hospital of Lianyungang
Hepatitis B, Chronic
1 trial -
Terbutaline
Hospital Authority, Hong Kong
Nonreassuring Fetal Status
1 trial -
Tests of the expression of CXCL3 in various tissues
The First People's Hospital of Lianyungang
Diabetic Kidney Disease (DKD)
1 trial -
Thoracic Paravertebral Block with Local Anesthetic
The First People's Hospital of Lianyungang
Pulmonary Nodules
1 trial -
Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses
Sinovac Research and Development Co.,
Poliomyelitis
1 trial -
Ticagrelor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Brain Disease
1 trial -
Tislelizumab combined with Lenvatinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Initially Unresectable Hepatocellular Carcinoma
1 trial -
Tolcapone
United Therapeutics Europe Ltd
Impulsive Behavior
1 trial -
Tolcapone
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Total intravenous anesthesia group
Xuzhou Medical University
Balanced Anesthesia
1 trial -
Tranexamic acid (TXA)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Blood Loss
1 trial -
Transdermal nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Treatment
United Therapeutics Europe Ltd
Glucose Metabolism Disorders
1 trial -
Trolamine (Biafine)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Tumour Biopsy and Venous Blood Tests
United Therapeutics Europe Ltd
Soft Tissue Sarcoma
1 trial -
UMULINE NPH
Takeda
Type 2 Diabetes
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Multiple Sclerosis (MS) - Relapsing-remitting
1 trial -
Ultra low dose chest computed tomography (ULDCT)
Hospital Authority, Hong Kong
Tuberculosis, Pulmonary
1 trial -
Ultrasound Elastography
Jazz Pharmaceuticals Ireland Limited
Bone Marrow Transplant Complications
1 trial -
Umbilical cord serum eyedrops
Hospital Authority, Hong Kong
Recurrent Corneal Erosion
1 trial -
Umooze
Biotech Pharmaceutical Co.,
Benign Prostatic Hyperplasia
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Environmental Exposure
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources